April 13, 2022

GSK buys Sierra Oncology for $1.9B

GlaxoSmithKline (GSK) acquired US-based biopharmaceutical Sierra Oncology for £1.5 billion ($1.9 billion), according to a joint press release on Wednesday.Sierra

US stocks higher at opening bell

US stocks opened higher Wednesday amid concerns about a more hawkish Federal Reserve along with turmoil in US bond markets.The